NMDA receptor subunit and CaMKII changes in rat hippocampus induced by acute MDMA treatment: A mechanism for learning impairment

Psychopharmacology

Volumn 173, Issue 3-4, 2004, Pages 337-345

  Moyano, S ^a   Frechilla, D ^a   Del Rio J ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

CaMKII; Ecstasy; Hippocampus; Learning; MDMA; Memory; NMDA receptor; PP1; Serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CALCINEURIN; FENCLONINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE 1; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AVOIDANCE BEHAVIOR; BRAIN MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; HIPPOCAMPUS; LEARNING DISORDER; MALE; MEMORY CONSOLIDATION; NEUROCHEMISTRY; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING;

ANIMALS; AVOIDANCE LEARNING; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; FENCLONINE; HIPPOCAMPUS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE; SEROTONIN; SEROTONIN AGENTS; SEROTONIN ANTAGONISTS;

EID: 2542629616     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-1816-8     Document Type: Article

References (43)

1. 1A receptor density and mRNA expression in rat hippocampus, frontal cortex and brainstem: the role of corticosteroids. J Neurochem 68:1099-1105
2. 3 receptor antagonist with anxiolytic-like properties in animal models. Psychopharmacology 117:137-148
3. Artaiz I, Del Río J, Lasheras B (1996) Impairment of passive avoidance behaviour in rats by MDMA ("ecstasy"). A comparison of acute and chronic treatments. Meth Find Exp Clin Pharmacol 18 (suppl B): 160
4. Barria A, Muller D, Derkach V, Griffith LC, Soderling TR (1997) Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276:2042-2045
5. Barrionuevo M, Aguirre N, Del Río J, Lasheras B (2000) Serotonergic deficits and impaired passive-avoidance learning by MDEA: a comparison with MDMA. Pharmacol Biochem Behav 65:233-240
6. Bayer K-U, Koninck PD, Leonard AS, Hell JW, Schulman H (2001) Interaction with the NMDA receptor locks CaMKII in an active conformation. Nature 411:801-805
7. Bolla KI, McCann UD, Ricaurte GA (1998) Memory impairment in abstinent MDMA ("ecstasy") users. Neurology 51:1531-1537
8. Byrne T, Baker LE, Poling A (2000) MDMA and learning: effects of acute and neurotoxic exposure in the rat. Pharmacol Biochem Behav 66:501-508
9. 2+/calmodulin-dependent protein kinase II activity and AMPA GluR1 subunit immunoreactivity. Eur J Neurosci 10:2669-2676
10. Cammarota M, de Stein ML, Paratcha G, Bevilaqua LR, Izquierdo I, Medina JH (2000) Rapid and transient learning-associated increase in NMDA NR1 subunit in the rat hippocampus. Neurochem Res 25:567-572
11. Clayton DA, Mesches MH, Alvarez E, Bickford PC, Browning MD (2002) A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat. J Neurosci 22:3628-3637
12. Cole JC, Sumnall HR (2003) The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). Neurosci Biobehav Rev 27:199-217
13. Dunah AW, Wang Y, Yasuda RP, Kameyama K, Huganir RL, Wolfe BB, Standaert DG (2000) Alterations in subunit expression, composition and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol Pharmacol 57:342-352
14. Endo S, Zhou X, Connor J, Wang B, Shenolikar S (1996) Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor. Biochemistry 35:5220-5228
15. Fink CC, Meyer T (2002) Molecular mechanisms of CaMKII activation in neuronal plasticity. Curr Opin Neurobiol 12:293-299
16. Frechilla D, García-Osta A, Del Río J (1999) Effect of p-chloroamphetamine and 3,4-methylenedioxymethamphetamine on CRE- and TRE-binding activity in rat frontal cortex and hippocampus. Soc Neurosci Abstr 174
17. Frederick DL, Ali SF, Slikker W, Gilliam MP, Allen RR, Paule MG (1995) Behavioral and neurochemical effects of chronic methylenedioxymethamphetamine treatment in rhesus monkeys. Neurotoxicol Teratol 17:531-543
18. Genoux D, Haditsch U, Knobloch M, Michalon A, Storm D, Mansuy IM (2002) Protein phosphatase 1 is a molecular constraint on learning and memory. Nature 418:970-975
19. Green AR, Mechan AO, Elliott JM, O'Shea E, Colado MI (2003) The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). Pharmacol Rev 55:463-508
20. 2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function. Annu Rev Biochem 71:473-510
21. Izquierdo I, Medina JH (1997) Memory formation: the sequence of biochemical events in the hippocampus and its connection to activity in other brain regions. Neurobiol Learn Mem 68:285-316
22. Jequier E, Lovenberg W, Sjoerdsma A (1967) Tryptophan hydroxylase inhibition: the mechanism by which p-chlorophenylalanine depletes rat brain serotonin. Mol Pharmacol 3:274-278
23. Leonard AS, Lim IA, Hemsworth DE, Home MC, Hell JW (1999) Calcium/calmodulin-dependent protein kinase II is associated with the AT-methyl-D-aspartate receptor. Proc Natl Acad Sci USA 96:3239-3244
24. Loftis JM, Janowsky A (2003) The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation and clinical implications. Pharmacol Ther 97:55-85
25. Lyles J, Cadet JL (2003) Methylenedioxymethamphetamine (MDMA, ecstasy) neurotoxicity: cellular and molecular mechanisms. Brain Res Rev 42:155-168
26. McCann UD, Mertl M, Eligulashvili V, Ricaurte GA (1999) Cognitive performance in 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology 143:417-425
27. 1A receptor involvement in passive avoidance in the rat. Br J Pharmacol 125:499-509
28. Morgan MJ (1999) Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology 141:30-36
29. Nihei MK, Desmond NL, McGlothan JL, Kuhlman AC, Guilarte TR (2000) N-Methyl-D-aspartate receptor subunit changes are associated with lead-induced deficits of long-term potentiation and spatial learning. Neuroscience 99:233-242
30. 1A receptors. Br J Pharmacol 128:1691-1698
31. Pérez-Otaño I, Herrero MT, Oset C, De Ceballos ML, Luquin MR, Obeso JA, Del Río J (1991) Extensive loss of brain dopamine and serotonin induced by chronic administration of MPTP in the marmoset. Brain Res 567:127-132
32. Riedel G, Platt B, Micheau J (2003) Glutamate receptor function in learning and memory. Behav Brain Res 140:1-47
33. Rodgers J (2000) Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology 151:19-24
34. Santucci AC, Knott PJ, Haroutunian V (1996) Excessive serotonin release, not depletion, leads to memory impairments in rats. Eur J Pharmacol 295:7-17
35. Shen K, Meyer T (1999) Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 284:162-166
36. Shobe J (2002) The role of PKA, CaMKII, and PKC in avoidance conditioning: permissive or instructive? Neurobiol Learn Mem 77:291-312
37. Suemaru J, Akiyama K, Tanabe Y, Kuroda S (2000) Methamphetamine decreases calcium-calmodulin dependent protein kinase II activity in discrete rat brain regions. Synapse 36:155-166
38. Taffe MA, Davis SA, Yuan J, Schroeder R, Hadzidimitriou G, Parsons LH, Ricaurte GA, Gold LH (2002) Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. Neuropsychopharmacology 27:993-1005
39. Tang Y-P, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) Genetic enhancement of learning and memory in mice. Nature 401:63-69
40. Thomas KL, Davis S, Laroche S, Hunt SP (1994) Regulation of the expression of NR1 NMDA glutamate receptor subunits during hippocampal LTP. Neuroreport 6:119-123
41. Verkes RJ, Gijsman HJ, Pieters MS, Schoemaker RC, de Visser S, Kuijpers M, Pennings EJ, de Bruin D, Van de Wijngaart G, Van Gerven JM, Cohen AF (2001) Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology 153:196-202
42. Williams JM, Guévremont D, Kennard JTT, Mason-Parker SE, Tate WP, Abraham WC (2003) Long-term regulation of N-methyl-D-aspartate receptor subunits and associated synaptic proteins following hippocampal synaptic plasticity. Neuroscience 118:1003-1013
43. 2+/calmodulin-dependent kinase II from postsynaptic densities. FEBS Lett 446:239-242